# Codex DNA Inc. (DNAY)

Source: https://www.quantisnow.com/company/DNAY
Generated: 2026-11-11T17:48:13.283Z

- Ticker: DNAY
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical Specialities
- IPO year: 2021
- Website: codexdna.com

## About

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries. The company also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

## Latest DNAY news and filings

- 2023-12-05 21:38 UTC [SEC Form 4] [SEC Form 4 filed by Kullback William J](https://www.quantisnow.com/insight/sec-form-4-filed-by-kullback-william-j-5120072)
- 2023-12-05 21:36 UTC [SEC Form 3] [SEC Form 3 filed by new insider Kullback William J](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-kullback-william-j-5120042)
- 2023-11-30 22:00 UTC [SEC Form 8-K] [Codex DNA Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/codex-dna-inc-filed-sec-form-8-k-entry-into-a-5111959)
- 2023-11-13 21:32 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Codex DNA Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-codex-dna-inc-5081444)
- 2023-11-13 21:32 UTC [SEC Form 8-K] [Codex DNA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/codex-dna-inc-filed-sec-form-8-k-results-of-operations-5081417)
- 2023-11-09 22:00 UTC [SEC Form 8-K] [Codex DNA Inc. filed SEC Form 8-K: Events That Accelerate or Increase a Direct Financial Obligation](https://www.quantisnow.com/insight/codex-dna-inc-filed-sec-form-8-k-events-that-accelerate-5076077)
- 2023-10-25 18:46 UTC [SEC Form 4] [Herrema Gregory J. was granted 153,191 shares (SEC Form 4)](https://www.quantisnow.com/insight/herrema-gregory-j-was-granted-153191-shares-sec-form-4-5037567)
- 2023-10-25 18:44 UTC [SEC Form 3] [SEC Form 3 filed by new insider Herrema Gregory J.](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-herrema-gregory-j-5037566)
- 2023-10-24 20:30 UTC [SEC Form 8-K] [Codex DNA Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/codex-dna-inc-filed-sec-form-8-k-leadership-update-5035595)
- 2023-09-22 21:00 UTC [SEC Form 8-K] [Codex DNA Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/codex-dna-inc-filed-sec-form-8-k-leadership-update-4984909)
- 2023-08-29 20:02 UTC [SEC Form 8-K] [Codex DNA Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/codex-dna-inc-filed-sec-form-8-k-leadership-update-other-4943116)
- 2023-08-11 10:01 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Codex DNA Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-codex-dna-inc-4881354)
- 2023-08-10 20:17 UTC [SEC Form 8-K] [Codex DNA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/codex-dna-inc-filed-sec-form-8-k-results-of-operations-4879160)
- 2023-08-04 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Codex DNA Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-codex-dna-inc-4846266)
- 2023-07-27 21:28 UTC [SEC Form S-3] [SEC Form S-3 filed by Codex DNA Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-codex-dna-inc-4808639)
- 2023-07-07 20:01 UTC [SEC Form 8-K] [Codex DNA Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/codex-dna-inc-filed-sec-form-8-k-entry-into-a-4731596)
- 2023-07-05 17:28 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Codex DNA Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-codex-dna-inc-amendment-4719540)
- 2023-07-05 17:24 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Codex DNA Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-codex-dna-inc-amendment-4719525)
- 2023-06-20 20:11 UTC [SEC Form D] [SEC Form D filed by Codex DNA Inc.](https://www.quantisnow.com/insight/sec-form-d-filed-by-codex-dna-inc-4661828)
- 2023-06-15 20:17 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by Codex DNA Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-codex-dna-inc-4648329)
- 2023-06-09 20:47 UTC [SEC Form 8-K] [Codex DNA Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/codex-dna-inc-filed-sec-form-8-k-unregistered-sales-of-4626275)
- 2023-06-08 22:12 UTC [SEC Form 4] [SEC Form 4 filed by Meister Paul M](https://www.quantisnow.com/insight/sec-form-4-filed-by-meister-paul-m-4622251)
- 2023-06-08 22:09 UTC [SEC Form 3] [SEC Form 3 filed by new insider Novalis Lifesciences Investments Ii Gp, Llc](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-novalis-lifesciences-investments-4622247)
- 2023-06-07 22:15 UTC [SEC Form 4] [SEC Form 4 filed by Northpond Ventures Gp, Llc](https://www.quantisnow.com/insight/sec-form-4-filed-by-northpond-ventures-gp-llc-4616574)
- 2023-06-07 21:00 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Codex DNA Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-codex-dna-inc-amendment-4616114)
- 2023-06-07 20:12 UTC [SEC Form 4] [SEC Form 4 filed by Broadoak Fund Iv, Llc](https://www.quantisnow.com/insight/sec-form-4-filed-by-broadoak-fund-iv-llc-4615418)
- 2023-06-07 20:11 UTC [SEC Form 4] [SEC Form 4 filed by Snider William](https://www.quantisnow.com/insight/sec-form-4-filed-by-snider-william-4615395)
- 2023-06-07 20:09 UTC [SEC Form 4] [SEC Form 4 filed by Nelson Todd Robert](https://www.quantisnow.com/insight/sec-form-4-filed-by-nelson-todd-robert-4615370)
- 2023-06-02 20:21 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Codex DNA Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-codex-dna-inc-amendment-4597196)
- 2023-05-31 21:25 UTC [SEC Form 8-K] [Codex DNA Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/codex-dna-inc-filed-sec-form-8-k-entry-into-a-4585585)
- 2023-05-24 20:15 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Codex DNA Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-codex-dna-inc-4554284)
- 2023-05-24 20:19 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Codex DNA Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-codex-dna-inc-4554202)
- 2023-05-24 20:22 UTC [SEC Form ARS filed by Codex DNA Inc.](https://www.quantisnow.com/insight/sec-form-ars-filed-by-codex-dna-inc-4554143)
- 2023-05-17 20:07 UTC [SEC Form 10-K] [SEC Form 10-K/A filed by Codex DNA Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-10-ka-filed-by-codex-dna-inc-amendment-4521349)
- 2023-05-17 20:03 UTC [SEC Form 10-K] [SEC Form 10-K/A filed by Codex DNA Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-10-ka-filed-by-codex-dna-inc-amendment-4521136)
- 2023-05-12 10:02 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Codex DNA Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-codex-dna-inc-4492255)
- 2023-05-11 20:16 UTC [SEC Form 8-K] [Codex DNA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/codex-dna-inc-filed-sec-form-8-k-results-of-operations-4489887)
- 2023-05-09 00:11 UTC [SEC Form 4] [SEC Form 4 filed by Nelson Todd Robert](https://www.quantisnow.com/insight/sec-form-4-filed-by-nelson-todd-robert-4465017)
- 2023-05-09 00:09 UTC [SEC Form 4] [SEC Form 4 filed by Gibson Daniel Glenn](https://www.quantisnow.com/insight/sec-form-4-filed-by-gibson-daniel-glenn-4465015)
- 2023-05-09 00:06 UTC [SEC Form 4] [SEC Form 4 filed by Cutler Rob](https://www.quantisnow.com/insight/sec-form-4-filed-by-cutler-rob-4465011)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/DNAY
- Earnings history: https://www.quantisnow.com/earnings/DNAY
- Dividend history: https://www.quantisnow.com/dividends/DNAY
- Insider transactions: https://www.quantisnow.com/insiders/DNAY
- Options chain: https://www.quantisnow.com/options/DNAY
- SEC 8-K filings only: https://www.quantisnow.com/company/DNAY/8-k
- RSS and alerts for DNAY: https://www.quantisnow.com/docs/rss-feeds.md